Autopsy report · NCT00596856
Development and Dissemination of Oral Health Risk Assessment and Referral Guidelines
Cause of deathOther
“Published study provided evidence that intervention would provide little effect; study not approved by provider community.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Conditions
- Early Childhood Dental Caries
- Interventions
- Development and dissemination of priority oral health risk assessment and referral guidelines - PORRT
- Participants
- 0
Trials that died the same way
- Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
“No efficacy could be demonstrated, sponsor decided to prematurely end the study.” - Coping Effectiveness Training for ALS
“The study was not funded.” - Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
“The study had poor efficacy.” - A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
“Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.” - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
“The study did not receive funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.